WASHINGTON, Oct. 20, 2011 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that net earnings from continuing operations for the quarter ended September 30, 2011 were $523.4 million, or $0.74 per share on a diluted basis, a 20% decrease as compared to diluted net earnings per share from continuing operations for the third quarter 2010. On a non-GAAP basis, which reflects the adjustments identified in the attached reconciliation schedule, third quarter 2011 adjusted diluted net earnings per share from continuing operations, were $0.73, a 26% increase over 2010 third quarter adjusted diluted net earnings per share from continuing operations.

Sales from continuing operations for the 2011 third quarter were $4.5 billion, 46% higher than the $3.1 billion reported sales from continuing operations for the 2010 third quarter. Core revenues increased 7.5% in the quarter compared to the third quarter of 2010.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, "We saw continued momentum across our businesses and were particularly pleased with our execution which led to outstanding year-over-year core revenue growth, core operating margin expansion, cash flow and earnings performance. As we are mindful that the environment is likely to be more challenging going forward, we anticipate increasing our previously announced fourth quarter restructuring efforts from approximately $50 million to approximately $100 million. This estimate excludes our ongoing cost reduction efforts at Beckman Coulter. Our focus on capturing market share while also accelerating cost actions in a slowing macro environment, coupled with a potentially more attractive acquisition environment, positions us well for the balance of 2011 and beyond."

Danaher will discuss its results during its investor conference call today starting at 8:00 a.m. EDT. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website at www.danaher.com. A replay of the webcast can be accessed on the "Investors" section of Danaher's website (under the subheading "Investor Events") shortly after the conclusion of the presentation, and the webcast will remain available until the next quarterly earnings call. The conference call can be accessed by dialing 800-967-7187 within the U.S. or 719-325-2339 outside the US a few minutes before the 8:00 a.m. EDT start and telling the operator that you are dialing in for Danaher's investor conference call, access code 4721216. A replay of the conference call will be available shortly after the conclusion of the call and through Thursday, October 27, 2011. You can access the replay by dialing 888-203-1112 within the U.S. or 719-457-0820 outside the U.S. with the access code 4721216. In addition, presentation materials relating to Danaher's results have been posted to the "Investors" section of Danaher's website under the subheading "Financial Information."

Danaher is a science and technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our premier brands are among the most highly recognized in each of the markets we serve. The Danaher Business System provides a foundation to our 59,000 associates around the world, serving customers in more than 125 countries. In 2010, we generated $12.8 billion of revenue. For more information please visit our website: www.danaher.com.

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings release also contains non-GAAP financial measures. The reasons why we believe these measures provide useful information to investors, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these measures are included in the supplemental reconciliation schedule attached.

Statements in this release that are not strictly historical, including the statements regarding the general economic environment, the Company's anticipated restructuring activities, the Company's focus on capturing market share, the acquisition environment, the Company's positioning and expectations for the balance of 2011 and future periods and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, uncertainty in the economy and financial markets, the impact of our restructuring activities on our ability to grow, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, our ability to successfully identify, consummate and integrate appropriate acquisitions (including our acquisition of Beckman Coulter, Inc. and our ability to effectively integrate the business and realize the anticipated benefits from the acquisition), contingent liabilities relating to acquisitions (including our acquisition of Beckman Coulter), risks relating to potential impairment of goodwill and other long-lived assets, currency exchange rates, our compliance with applicable laws and regulations (including regulations relating to medical devices and the healthcare industry) and changes in applicable laws and regulations, our ability to effectively address cost reduction and other changes in the healthcare industry, tax audits and changes in our tax rate and income tax liabilities, litigation and other contingent liabilities including intellectual property and environmental matters, risks relating to product defects and recalls, the impact of our debt obligations on our operations, pension plan costs, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, labor matters, our relationships with and the performance of our channel partners, risks relating to man-made and natural disasters, our ability to achieve projected cost reductions and growth, and international economic, political, legal and business factors. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2010 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the third quarter of 2011. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

                                       DANAHER CORPORATION
                                       -------------------
                          CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
                          ---------------------------------------------
                      ($ and shares in thousands, except per share amounts)
                                           (unaudited)

                            Three Months Ended          Nine Months Ended
                            ------------------          -----------------
                          September                September
                             30,      October 1,      30,      October 1,
                                2011        2010         2011        2010
                                ----        ----         ----        ----

    Sales                 $4,518,089  $3,092,836  $11,575,465  $9,318,093
    Cost of sales          2,313,427   1,480,901    5,664,220   4,631,893
                           ---------   ---------    ---------   ---------
    Gross profit           2,204,662   1,611,935    5,911,245   4,686,200

    Operating costs
     and other:
        Selling, general
         and
         administrative
         expenses          1,274,907     872,935    3,340,358   2,635,854
        Research and
         development
         expenses            289,602     196,437      742,978     568,472
        Earnings from
         unconsolidated
         joint venture       (15,991)    (10,550)     (44,926)    (10,550)
                                         -------      -------     -------

    Operating profit         656,144     553,113    1,872,835   1,492,424

    Non-operating
     income
     (expense):
         Gain on
          contribution of
          businesses to
          joint venture           --     291,037           --     291,037
         Loss on early
          extinguishment
          of debt            (32,887)         --      (32,887)         --
         Interest expense    (42,760)    (31,248)    (105,194)    (90,236)
         Interest income         392       1,777        4,787       4,369
                                 ---       -----        -----       -----

    Earnings from
     continuing
     operations
     before income
     taxes                   580,889     814,679    1,739,541   1,697,594

    Income taxes             (57,461)   (180,875)    (346,221)   (408,921)
                             -------    --------     --------    --------

    Earnings from
     continuing
     operations              523,428     633,804    1,393,320   1,288,673

    Earnings from
     discontinued
     operations, net
     of income taxes              --      12,631      208,230      30,471
                                 ---      ------      -------      ------

    Net earnings            $523,428    $646,435   $1,601,550  $1,319,144
                            ========    ========   ==========  ==========
    Earnings per
     share from
     continuing
     operations:
          Basic                $0.76       $0.97        $2.07       $1.98
                               -----       -----        -----       -----
          Diluted              $0.74       $0.93        $2.00       $1.90
                               =====       =====        =====       =====
    Earnings per
     share from
     discontinued
     operations:
          Basic                  $--       $0.02        $0.31       $0.05
                                 ---       -----        -----       -----
          Diluted                $--       $0.02        $0.30       $0.04
                                 ===       =====        =====       =====
    Net earnings per
     share:
          Basic                $0.76       $0.99        $2.38      $2.02*
                               -----       -----        -----       -----
          Diluted              $0.74       $0.95        $2.30      $1.95*
                               =====       =====        =====       =====
    Average common
     stock and
     common
     equivalent
     shares
     outstanding (in
     thousands):
          Basic              687,259     654,599      672,022     651,995
          Diluted            710,403     683,431      697,777     681,964

    * Earnings per share amounts do not add due to rounding.

A complete copy of Danaher's Form 10-Q financial statements is available on the Company's website (www.danaher.com)

    DANAHER CORPORATION
    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
    ($ in 000's except per share data)

                                                       Three Months Ended                       Nine Months Ended
                                                       ------------------                       -----------------
    Adjusted Net Earnings from                    September 30,    October 1,             September 30,   October 1,
     Continuing Operations                             2011           2010      % Change       2011            2010    % Change
    --------------------------                   --------------   -----------   --------  --------------  -----------  --------

    Net Earnings from Continuing
     Operations (GAAP)                                  $523,428      $633,804     -17.4%     $1,393,320    $1,288,673       8.1%
                                                                                   =====                                     ===

      Acquisition-related transaction
       costs deemed significant                           70,717         5,777                   112,065        40,671
      ($0 and $26 million pre-tax for
       each of the three and
      nine months ended September 30,
       2011, respectively,
      and $8 million pre-tax for the
       nine months ended
      October 1, 2010), fair value
       adjustments to acquisition
      related inventory and deferred
       revenue balances and
      change-in-control payments to
       employees of Beckman
      Coulter ($93 million and $122
       million pre-tax for the
      three and nine months ended
       September 30, 2011,
      respectively, and $8 million and
       $46 million pre-tax for
      the three and nine months ended
       October 1, 2010,
      respectively) ("Acquisition
       Related Costs")

      Loss on early extinguishment of
       debt resulting from                                20,790                                  20,790
      "make whole" payments associated
       with the retirement
      of certain of the acquired
       Beckman Coulter debt ($33
      million pre-tax) ("Loss on Early
       Extinguishment of
      Debt")

      Reversal of reserve relating to
       legal contingency ($12                             (8,915)                                 (8,915)
      million pre-tax) ("Legal
       Contingency")

      Gain on contribution of assets to
       Apex joint venture                                      -      (232,200)                        -      (232,200)
      ($291 million pre-tax for the
       three and nine months
      ended October 1, 2010,
       respectively) ("Joint Venture
      Gain")

      Gains from net reduction in
       income tax reserves, other                        (90,656)      (14,586)                  (93,528)      (18,613)
      discrete tax items and reduction
       of effective tax rate
      ("Income Tax Items")


    Adjusted Net Earnings from
     Continuing Operations                              $515,364      $392,795      31.2%     $1,423,732    $1,078,531      32.0%
    (Non-GAAP)                                          ========      ========      ====      ==========    ==========      ====

    Adjusted Diluted Net Earnings Per Share from
     Continuing
    --------------------------------------------
    Operations
    ----------

    Diluted Net Earnings Per Share
     from Continuing Operations
     (GAAP)                                                $0.74         $0.93     -20.4%          $2.00         $1.90       5.3%
                                                                                   =====                                     ===

      Acquisition Related Costs                             0.10          0.01                      0.16          0.06

      Loss on Early Extinguishment of
       Debt                                                 0.03             -                      0.03             -

      Legal Contingency                                    (0.01)            -                     (0.01)            -

      Joint Venture Gain                                       -         (0.34)                        -         (0.34)

      Income Tax Items                                     (0.13)        (0.02)                    (0.14)        (0.03)


    Adjusted Diluted Net Earnings Per
     Share from                                            $0.73         $0.58      25.9%          $2.04         $1.59      28.3%
    Continuing Operations (Non-GAAP)                       =====         =====      ====           =====         =====      ====

    Core Revenue Growth
    -------------------

     Components of Revenue Growth         Three Months    Nine Months
     ----------------------------             Ended          Ended
                                          September 30,  September 30,
                                             2011 vs.       2011 vs.
                                            Comparable     Comparable
                                           2010 Period    2010 Period
                                           -----------    -----------

     Core (non-GAAP)                                7.5%           8.5%
     Acquisitions (net of reduction in
      revenues relating to Apex                    35.0%          12.5%
     JV) (non-GAAP)
     Impact of currency translation (non-
      GAAP)                                         3.5%           3.0%
                                                    ---            ---
     Total Revenue Growth (GAAP)                   46.0%          24.0%
                                                   ====           ====

Adjusted Net Earnings from Continuing Operations and Adjusted Diluted Net Earnings Per Share from Continuing Operations

We disclose the non-GAAP measures of adjusted net earnings from continuing operations and adjusted diluted net earnings per share from continuing operations, which refer to GAAP net earnings from continuing operations and GAAP diluted net earnings per share from continuing operations, respectively, excluding the items identified in the reconciliation schedule above. These non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Management believes that these measures provide useful information to investors by reflecting additional ways of viewing aspects of Danaher's operations that, when reconciled to the corresponding GAAP measures, help our investors to better understand the long-term profitability trends of our business, and facilitate easier comparisons of our profitability to prior and future periods and to our peers. The items described above have been excluded from these measures because items of this nature and/or size occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher's commercial performance during the period and/or we believe are not indicative of Danaher's ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult. The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company's larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.

The Company estimates the tax effect of the items identified in the reconciliation schedule above by applying the Company's overall estimated effective tax rate to the pre-tax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.

Core Revenue and Core Revenue Growth

We use the term "core revenue" or "sales from existing businesses" to refer to GAAP revenue excluding (1) sales from acquired businesses recorded prior to the first anniversary of the acquisition ("acquisition sales"), (2) 2010 sales attributable to the businesses contributed to the Apex joint venture, and (3) the impact of currency translation. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in GAAP revenue (excluding sales from acquired businesses and 2010 sales attributable to the businesses contributed to the Apex joint venture) and (b) the period-to-period change in revenue (excluding sales from acquired businesses and 2010 sales attributable to the businesses contributed to the Apex joint venture) after applying current period foreign exchange rates to the prior year period. We use the term "core revenue growth" to refer to the measure of comparing current period core revenue with the corresponding period of the prior year. These non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Management believes that these measures provide useful information to investors by reflecting additional ways of viewing aspects of Danaher's operations that, when reconciled to the corresponding GAAP measures, help our investors to better identify underlying growth trends in our business and facilitate easier comparisons of our revenue performance with prior and future periods and to our peers. We exclude the effect of currency translation from these measures because currency translation is not under management's control, is subject to volatility and can obscure underlying business trends. We exclude the effect of acquisitions because the nature, size and number of acquisitions can vary dramatically from period to period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult. We exclude the effect of the 2010 sales attributable to the businesses contributed to the Apex joint venture because as a result of application of the equity method of accounting beginning with the formation of the joint venture on July 4, 2010, the Company did not recognize sales from those businesses in the first nine months of 2011.

SOURCE Danaher Corporation

SOURCE: Danaher Corporation